Back
Biodexa Pharmaceuticals PLC Vs. NuCana PLC Industry Stock Comparison
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
4.80
Seasonality Move:
-23.1%
Sell
35
NCNA
NuCana PLC
Last Price:
1.28
Seasonality Move:
12.07%
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals PLC [BDRX] share price is $4.80. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
NuCana PLC (NCNA)
is a Sell
Is NuCana PLC a Buy, Sell or Hold?
- The current NuCana PLC [NCNA] share price is $1.33. The Score for NCNA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- NCNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $4.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRX is experiencing slight buying pressure.
NCNA Stock Price Chart
What is NuCana PLC's stock price today?
-
The NuCana PLC share price today is $1.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 44.69 | Sell |
| Chaikin Money Flow: | 2455 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.32 - 6.3) | Sell |
| Bollinger Bands (100): | (-0.01 - 4.89) | Buy |
NCNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 34.15 | Sell |
| Chaikin Money Flow: | 72553 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.35 - 1.71) | Sell |
| Bollinger Bands (100): | (1.27 - 4.85) | Sell |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.18 | Buy |
| 20-day SMA: | 4.98 | Sell |
| 50-day SMA: | 4.22 | Buy |
| 200-day SMA: | 1.78 | Buy |
| 8-day EMA: | 4.56 | Buy |
| 20-day EMA: | 4.76 | Buy |
| 50-day EMA: | 4.18 | Buy |
| 200-day EMA: | 11.99 | Sell |
NCNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.33 | Buy |
| 20-day SMA: | 1.47 | Sell |
| 50-day SMA: | 1.98 | Sell |
| 200-day SMA: | 4.17 | Sell |
| 8-day EMA: | 1.34 | Sell |
| 20-day EMA: | 1.5 | Sell |
| 50-day EMA: | 2.05 | Sell |
| 200-day EMA: | 4.86 | Sell |
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
NuCana PLC Earnings Growth & NCNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.06 per share, and a decrease next year of $7.72 per share.
Biodexa Pharmaceuticals PLC Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NuCana PLC Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||